For women who do breastfeed, the decision about when to start or restart semaglutide involves weighing the benefits of continued breastfeeding against the benefits of weight loss or diabetes management and the unknown risks of medication exposure through breast milk
Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on Visceral Obesity
Wegovy, Oral Wegovy, Zepbound, and Foundayo are all FDA-approved specifically for chronic weight management, and Klinic prescribes all of them
However, stimulant laxatives should be used cautiously, as overuse may disrupt natural bowel rhythms
If you typically consume 2,000 calories a day, your daily intake would drop to 1,500 calories
Bone Health: There have been concerns about potential effects on bone health, but further research is needed to establish a clear link between semaglutide and bone-related issues